The US Food and Drug Administration’s plan to address concerns about its food safety operations will mean changes for the allocation of resources in the Office of Regulatory Affairs that will have implications for drug inspections.
FDA announced a “
US FDA Food Safety Overhaul Will Have Ripple Effects For Drug Inspections
A restructuring of FDA’s food safety operations includes changes to the agency-wide office that handles all inspections, including those of drug manufacturers. It’s another shift in the delicate balancing of centralized management of ORA with the specific needs and priorities of the different centers.
